These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16918222)

  • 1. The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral palsy.
    Criswell SR; Crowner BE; Racette BA
    Neurosurg Focus; 2006 Aug; 21(2):e1. PubMed ID: 16918222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.
    Kawano A; Yanagizono T; Kadouchi I; Umezaki T; Chosa E
    J Orthop Sci; 2018 Mar; 23(2):389-393. PubMed ID: 29146092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
    Koman LA; Paterson Smith B; Balkrishnan R
    Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
    J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
    Ade-Hall RA; Moore AP
    Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cerebral palsy with botulinum toxin: evaluation with gross motor function measure.
    Yang TF; Chan RC; Chuang TY; Liu TJ; Chiu JW
    J Formos Med Assoc; 1999 Dec; 98(12):832-6. PubMed ID: 10634023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of therapeutic botulinum toxin in the treatment of cerebral palsy.
    Pidcock FS
    J Pediatr; 2004 Aug; 145(2 Suppl):S33-5. PubMed ID: 15292885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC; Lin IL; Chou TF; Lee HM
    J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper extremity function and occupational performance in children with spastic cerebral palsy following lower extremity botulinum toxin injections.
    Keren-Capelovitch T; Jarus T; Fattal-Valevski A
    J Child Neurol; 2010 Jun; 25(6):694-700. PubMed ID: 20508235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computerized gait analysis of botulinum toxin treatment in children with cerebral palsy.
    Galli M; Cimolin V; Valente EM; Crivellini M; Ialongo T; Albertini G
    Disabil Rehabil; 2007 Apr; 29(8):659-64. PubMed ID: 17453987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials.
    Farag SM; Mohammed MO; El-Sobky TA; ElKadery NA; ElZohiery AK
    JBJS Rev; 2020 Mar; 8(3):e0119. PubMed ID: 32224633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
    Teasell R; Foley N; Pereira S; Sequeira K; Miller T
    Top Stroke Rehabil; 2012; 19(2):115-21. PubMed ID: 22436359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary.
    Kim H; Kolaski K
    NeuroRehabilitation; 2021; 49(1):161-164. PubMed ID: 34366300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary trial of botulinum toxin A therapy for lower extremity spasticity in children with cerebral palsy].
    Nezu A; Ichikawa K; Takeshita S
    No To Hattatsu; 2008 Jan; 40(1):15-9. PubMed ID: 18210858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spasticity in children cerebral palsy: diagnosis and treatment strategies].
    Kurenkov AL; Batysheva TT; Vinogradov AV; Ziuziaeva EK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(7 Pt 2):24-8. PubMed ID: 23330188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of botulinum toxin a in the management of lower limb spasticity in patients with cerebral palsy.
    Dursun N; Dursun E; Alican D
    Int J Clin Pract; 2002 Oct; 56(8):564-7. PubMed ID: 12425363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.